What We're Reading: Counterfeit Weight Loss Drugs; COVID-19–Flu Vaccine Enters Phase 3 Trial; CMS Limits Predictive Software Use

FDA is investigating fraudulent schemes trafficking counterfeit semaglutide (Ozempic); Moderna plans to begin a late-stage trial of its combined COVID-19 and flu vaccine later this year; CMS will begin restricting predictive software used by insurance companies next year.

Related Keywords

, Cargo Security Coalition , Pfizer , Pharmaceutical Cargo Security Coalition , Late Stage Trial , Flu Combo , Ozempic , Weight Loss Drug , Covid Flu Combo Vaccine , Moderna , Predictive Software , Medicare Advantage , Cms , Ewwr , What We X27 Re Reading ,